Candida albicans (Candida albicans) is one of the major sources of nosocomial infections in humans which may prove fatal in 30% of cases. The hospital acquired infection is very difficult to treat affectively due to the presence of drug resistant pathogenic strains, therefore there is a need to find alternative drug targets to cure this infection. In silico and computational level frame work was used to prioritize and establish antifungal drug targets of Candida albicans. The identification of putative drug targets was based on acquiring 5090 completely annotated genes of Candida albicans from available databases which were categorized into essential and non-essential genes. The result indicated that 9% of proteins were essential and could become potential candidates for intervention which might result in pathogen eradication. We studied cluster of orthologs and the subtractive genomic analysis of these essential proteins against human genome was made as a reference to minimize the side effects. It was seen that 14% of Candida albicans proteins were evolutionary related to the human proteins while 86% are non-human homologs. In the next step of compatible drug target selections, the non-human homologs were sequentially compared to the human microbiome data to minimize the potential effects against gut flora which accumulated to 38% of the essential genome. The sub-cellular localization of these candidate proteins in fungal cellular systems indicated that 80% of them are cytoplasmic, 10% are mitochondrial and the remaining 10% are associated with the cell wall. The role of these non-human and non-gut flora putative target proteins in Candida albicans biological pathways was studied. Due to their integrated and critical role in Candida albicans replication cycle, four proteins were selected for molecular modeling. For drug designing and development, four high quality and reliable protein models with more than 70% sequence identity were constructed. These proteins are used for the docking studies of the known and new ligands (unpublished data). Our study will be an effective framework for drug target identifications of pathogenic microbial strains and development of new therapies against the infections they cause.
INTRODUCTION
Drug discovery process starts with identification of the drug target (Chan et al., 2010) , and provision of a complete fungal/pathogen genome sequence has sped up this procedure. Due to the availability of both, pathogen and host genome sequences, through international institutions hosting systems such as Entrez which contain databases like NCBI, identification of drug targets at the genomic level has become easier for any given pathogen (Marton et al., 1998) . Historically, targets were identified based on the knowledge related to the function of each individual protein molecule involved in various steps of the reaction. This procedure not only incurredhuge costs in terms of finances, but also in terms of the time which increased the cost of research and grew steeply and steadily in the last few decades (Volkswirtschaftliche, 2005) . The advantages of using in silico methods are speed, low cost and provision of viewing whole microbes as a complete system. These methods have advantage of asking questions which were otherwise difficult to address especially experimentally. Now instead of using ligand based approaches to target individual molecules, in-silico approach can target molecular pathways of the disease (Mdluli & Spigelman, 2006) .
Inthe last decades there was paradigm shift in discovering novel targets by drug designing based on genomics, proteomics and metabolomics approaches, especially for drug resistant pathogens (Lin & Qian, 2007; Fischbach & Walsh, 2010) . The most common approach is based on genomics and specifically, in silico comparative, subtractive and functional genomics are used to identify new drug targets for effective antifungal agents against the fungal pathogens which are becoming resistant to existing regimens in certain setting (Ji, 2002; Pucci, 2006) . It is usually proposed that analysis at the level of a system involving genes, proteins and interactions between them provide a deep insight into the route required for drug targets and resistance profile of pathogen. The pre- Vol. 65, No 2/2018 209-218 https://doi.org/10.18388/abp.2017_2327
requisite of any such analysis required the presence of a protein interactome of a given pathogen (Raman & Chandra, 2008) . Candida albicans is a diploid fungal pathogen, harmless to nearly 70% of the human population, while nearly 75% of women suffer from its infection at least once in their lifetime (Meiller et al., 2009; Schulze & Sonnenborn, 2009 ). Candida albicans turn into an opportunistic organism for immunocompromised patients and causes a disease known as candidiasis. Candidiasis is categorized as a spotty white infected membrane known as "thrush" in GIT epithelial cells, vaginal or oropharyngeal mucosa, or a life threatening infection in severely ill patients, with mortality rate of 30% (Scully, EI-Kabir, & Samaranayake, 1994; Soll et al., 1988) . Candida speciesare the fourth largest cause of cardiovascular and blood stream infections with mortality rate as high as 50% among infected patient in the US (Kabir et al., 2012) . It causes infection by changing different phenotypic states playing a particular role in infection, by displaying certain external proteins and by secreting digestive enzymes (Braun et al., 2005) . Candida albicans has different strategies for its survival against treatment by having a thick cell wall and by releasing aspartic proteases which prevent opsonization by cleaving C3b (a component of complementary protein formed by cleavage of Component C3 used in cascade reaction for generation of killing protein) (Riesbeck, 2013; Garcı, 2004) .
Here, we report a comprehensive framework for analysis of the entire Candida albicans genome to identify and prioritize alternative and novel drug target proteins (Fig. 1) . This systems level approach involves (i) the use of genome databases and biological network tools (ii) analysis of network-based relationships between the essential and non-essential proteins (iii) using subtractive and comparative genomic analysis to minimize the risks of disturbing human gastrointestinal microbial flora (iv) predict subcellular localization of drug targets, and (v) integrated pathways analysis and modeling of targeted proteins. This study emphasized on the importance of computational analysis and its potential as generalized strategy for identification of putative drug targets of pathogenic strains.
MATERIAL AND METHODS
Candida albicans genome coverage. The categorized annotated gene and protein sequences of Candida Figure 1 . Steps involved in identification and prioritization of putative protein targets of Candida albicans using systems biology approach Protein drug targets of Candida albicans albicans strain SC3514 in FASTA format were downloaded and retrieved from the Fungidb database (http:// fungidb.org/common/downloads/release-2.0/Calbicans_ SC5314/fasta/data/, n.d.). All of the tools and softwares used in this study are listed in Table 1 . The Candida albicans genome delivers a lot of information regarding overall conservation, role categories and therapeutic potential of antifungal targets. These genes coded for essential and non-essential proteins, as well as other regulatory factors. A complete genome of this species comprises 15.7mb, with the totalof 5090 genes. Out of 5090 coding genes, only 1205 have role category. The general feature of the Candida albicans genome is shown in Table 2 . The methodology has been illustrated in Fig. 1 .
Screening of essential genes. The Database of Essential Genes (DEG) was used for screening of essential genes (Luo et al., 2014; Zhang & Lin, 2009; Zhang et al., 2004) andsequence alignments were done by using the BLASTp function of the database of essential genes against each gene and protein sequence of the pathogen. The cut off parameter was set at a minimum 100 bit score (> 80% identity), along with 0.0001 expectation value-for short listing the essential genes (Barh et al., 2011) .
Comparative analysis against human genome. Essential protein sequences of Candida albicans were queried to NCBI for finding human homolog and non-human homolog proteins. The BLASTp algorithm of NCBI was used forhuman-homologs based on E=1 cutoff and sequence similarity of less than 50% at the NCBI server (Muhammad et al., 2014) .
Comparative analysis against human microbiota. Many different kinds of organisms are present to in the gut of normal healthy individuals and they perform a very important function in the health and disease of an individual (Garcı, 2004) . They not only participate in a commensal relationship between the gut flora and humans,but their role is more than mutualism (Arias & Murray, 2009 ). The microorganisms perform many useful functions such as fermentation, enhancing the immune system, preventing harmful species growth (Guarner & Malagelada, 2003) , gut developmental regulation, vitamins production and defending host against various diseases (Arias & Murray, 2009) . If proteins of these microorganisms wereinhibited, then there was a number of side effects (Riesbeck, 2013) . To overrule this possibility and to screen out the matched proteins the short listed NHHG (non-human homolog genes) of Candida albicans were compared to proteins of the gut flora by sequence analysis with cutoff value (E=0.01) and bit score (>100) at the Human Microbiome Project Database server (Lewis, 2013) .
Protein-protein interaction (PPI) studies. The functional annotation and topology analysis was done using protein-protein interactions in the Candida albicans system to examine the role of each proteins in a cellular system. For this analysis, the interacting proteins of selected non-human and non-gut flora homologs (NHNGH) were retrieved from the STRING database version 10 with confidence score of >7.0 (Szklarczyk et al., 2011). The PPI-network was constructed by using the Cytoscape software (Bauer-Mehren, 2013) . Prediction of sub-cellular localization. NHNGHwerefound to be the potential fungal targets and their sub-cellular localization (Cytoplasmic membrane, secreted inside cell or secreted extracellularly) were important due to access of drug ligand to the putative target. This localization of NHNGHwere predicted for biological significance and distribution of these target genes by using CELLO v 2.5 sub-cellular localization prediction tool (Lu et al., 2004) .
Pathway analysis. The interaction between integrated metabolic and protein network of Candida albicans was analyzed and it was found that a correlation existed between these pathways. The identified sequences, which were essential, non-human and non-gut flora homolog genes, were mapped to metabolic pathways. Metabolic pathways were prepared using KEGG database (Altschul et al., 1997) . For individual genesanalysis, gene ontology (GO) network was created for cataloging the homologous pathways with in fungus. This analysis also showed those pathways which were absent in the host but were present in the Candida albicans.
Protein structure modeling and posttranslational modifications (PTMs). For structure based drug design, there is a need ofprotein structure with accurate conformation (Rausch et al., 2014) . The selected essential non-human and non-gut flora homolog protein sequences whose structures were not available in the existing protein databases were comparatively modelled with maximum homology (Arnold et al., 2006) using online SWISS-MODEL server (Bordoli et al., 2009) . The stereo-chemical quality of these protein models were based on the Q-means and Z-score Benkert et al., 2011) . Further, we predicted the posttranslational modifications (PTMs) of these protein models by sequencebased predictors. We used different statistical tools of the ExPASY resource server (https:// www.expasy.org/, n.d.). The protein sequences of these models were analyzed for N-glycosylation, acetylation, O-glycosylation with N-Acetylglucosamine (GlcNAc) or NAcetylgalactosamine (GalNAc) and phosphorylation with NetAcet (Kiemer et al., 2005) , NetNGlyc NetOGlyc (Steentoft et al., 2013) , YinOYang , and NetPhos (Blom et al., 1999; Jensen et al., 2002) , respectively. In this study the probability of palmitoyl chains bound to free cysteine side chains was also examined CSS-Palm (Ren et al., 2008) .
RESULTS

Finding of essential genes
The database of essential gene was used for homologous sequence search of individual fungal proteins using BLASTp options. Based on the cutoff parameters, we shortlisted 538 essential proteins which are associated with various structural and physiological functions.
Orthology analysis with Homo sapiens
Each essential protein sequence of Candida albicans was analyzed for sequence homology with human genome using standard human BLASTp at the NCBI server with an E-value cutoff of 1. The comparative analysis was performed to exclude the human homolog proteins and to retain non-human homolog protein sequences. 464 genes out oftotal 538 protein sequences were found to be non-human homologous sequences, while 160 genes of these 464 were found to be conserved.
Comparative analysis with human microbiota
The most commonly used antibiotics kill pathogenic microbiota and healthy microbial flora non-selectively. This had a profound and prolonged harmful impact on normal gut flora (Jernberg, Löfmark, Edlund, & Jansson, 2010) , so here efforts to design novel drugs that specifically targetthe fungus proteins. The short listed 464 essential proteins were compared with the gut flora by sequence analysis. The outcomes of sequence homolog analysis revealed that 20 (4.4%) were non-homologous to the gut flora (Fig. 2) , and these may be further used for interactomic analysis and designing of drug ligand to cure the disease. The complete list of putative targets is provided as a supporting document (Supplementary Table 1 at www.actabp.pl).
Interactomic network
To understand and analyze the topology and functional annotation of protein-protein interaction in Candida albicansa protein networks was constructed (20-proteins) that contained 111-nodes and 122-edges. The entire protein network consisted of high confidence scoring partners (STRING relevant confidence score >0.8). The main component of this network connected nodes and edges (nodes represent protein and edges represent interaction). In Fig. 3 , the interaction network was largely segregated into three neighborhoods: one enriched for modelled proteins shown in dark green among light green nodes representing potential drug targets and blue nodes indicates the interacting proteins with source proteins. The network was analyzed by Cytoscape network statistics with undirected score based on the centrality relationship among nodes.
The topological analysis of this network revealed the direct interaction of these critical and essential proteins that can be probable drug targets. 20 proteins were mapped to the PPI network. The visual analysis of this network showed that not only these essential proteins interact with each other and but were involved also in biosynthesis of amino acids signal transduction systems, nucleic acid synthesis, ribosomal proteins-functioning and other physiological transportation of chemicals and neurotransmitter.
Prediction of sub-Cellular localization
We predicted sub-cellular localization of the putative 20 target proteins. Among these targets, 80% of the proteins belonged to the cytoplasmic compartment, followed by the membrane associated protein (10%) and extracellular proteins (10%) (Fig. 4) .
Identifying pathways of potential drug targets
The role of the 20 sorted proteins in the metabolic pathways of Candida albicans was studied and correlated by KEGG database (Fig. 5 ). An illustrated map of the metabolic network was created showing system level investigations of this fungus'cell machinery. The 20 inputs genes encode enzymes important in various biochemical reactions related to 40 pathways (KEGG database). These reactions include carbohydrate metabolism, protein synthesis, and its degradation, two component systems, phosphotransferase system, cofactor biosynthesis, DNA synthesis and others.
Protein modeling and analysis of posttranslational modification
Among the potential drug targets of Candida albicans, four proteins including RNA polymerase I, orotidine 5 phosphate decarboxylase, ubiquitin-like protein-conjugating E2 enzyme and serine-theonine phosphatase5 were selected based on the maximum homology of protein models and critical analysis of the pathways. The protein models of these potential targets were validated by the Q-Mean and Z-score which shows that the geometry and conformation of these protein models are stable (Fig. 6) .
The post translation modifications showed that according to the NetAcet server, for Sequence 5 (Orotidine 5-phosphate decarboxylase), sequence 17 (ubiquitinlike protein-conjugating E2 enzyme) and sequence 20 (delta14-sterol reductase), acetylationis not possible as there is no alanine, glycine threonine and serine at this position. The sequence 12 (serine/threonine-protein phosphatase 5) and sequence 14 (RNA polymerase I) show positive results as acetylation is possible in bothproteins. Similarly, According to NetAcet server, Sequence 5 (hexokinase), sequence 17 (ubiquitin-like protein-conjugating E2 enzyme) and sequence 20 (delta14-sterol reductase), the acetylation of this protein is not possible as there of no alaline, glycine threonine and serine at this position. The sequence 12 (serine/threonineprotein phosphatase 5) and sequence 14 (RNA polymerase I) show positive results as acetylation is possible in both proteins.For each sequence, potential glycosylation sites or location are identified by using prediction confidence of predicted score higher than 0.5. The NetPhos prediction indicated about the presence of serine threonine and tyrosine phosphorylation sites in our protein for specific and general kinases. This site predicts for following kinases: ATM CKI CKII CAMII DNAPK EGFR GSK3 INSR PKA PKB PKC RSK SRC cdc2 cdk5 p38MAPK. We predicted that serine/ threonine residues of protien are used to predict it O-GlcNAcylated as well as phosphorylated in YinOYang prediction, these sites are acylated reversibly at different time for Maximum sequence identity percentage shows the strength of the predicted model. The quality of the model was estimated by Z-score and Q-MEAN. These Ramachandran plots of top four predicted protein models wereconstructed by Drug Discovery Studio version 3.0 and indicated that the amino acid residues occur in the "favored region" (saturated green nodes) and few in "disallowed region" of the plot. For a good protein model there must be ≥90% amino acid residues in the most favored region or <2% in the disallowed region of the plot. the different function performed in the cell. None of the proteins in our scheme showed YinOYong positive results (Table 3) .
DISCUSSION/CONCLUSION
Alternative drug targets are needed for nosocomial Candida albicans infections, as this fungus has become resistant to all therapies currently available (Arias & Murray, 2009; Boyanova et al., 2007) . One innovative way is to target genes essential for fungal survival. The product of such essential gene could become a new antifungal drug target . In this study, we found that in Candida albicans 20 proteins were potential targets which were non-homologous to human genes as well as the gut flora. These proteins are recommended as drug targets having minimum side effects. By having a deep knowledge on a biological system by using genomic databases and system biological studies we can formulate better drugs. These systems help us to explore various pathways to find the most appropriate drugs by exploration of pathways and whole cellular systems which are involved in given disease. Computational systems help us in assessing the criticalness of any individual protein by studying the involvement of that proteins in alternative pathways or to the alternative pathway mechanismsthat compensate for that protein. System level studies are making it clearer day by day that a whole new plethora of techniques may be used for simulation and analysis of biochemical systems (von Mering et al., 2007; Szklarczyk et al., 2011) .
The protein network map shows the behavior of essential and non-essential proteins. Protein-protein interaction are comprehensive due to availability of experimentally mapped interactionsin the integrated databases (Perumal et al., 2007) . Along with the essentiality of a selected protein target for Candida albicans. The other most common requirement is non-similarity with human proteins. Inhibition of the human proteins could lead to adverse effects. Querying the selected proteins against human proteome data at NCBI and UNIPROT databases was simplest and efficient way to achieve this. Sequence information for hundreds of eukaryotes/ prokaryotes is available and this kind of analysis has been reported for Mycobacterium tuberculosis,Pseudomonas and Helicobacter species (Singh et al., 2006; Beaugerie & Petit, 2004) .
The role of normal human flora is ecological balance of the body system along with controlling the human mood and immunity (O'Hara & Shanahan, 2006; Hugot, 2004; Payne et al., 2003; Carman et al., 2004) . The normal flora usually resides in digestive tract, upper respiratory tract and otic region of the human body and perform immunity control, mood regulation, synthesis of vitamins and prevention of superinfections. The metabolic activities performed by microflora of any species is now considered equal to a virtual organ which might be named as a forgotten organ (Guarner & Malagelada, 2003) . Broad spectrum antibiotics affect the host's health by changing composition of the gut flora (Carman et al., 2004) . Due to this reason, non-human homologous sequences could not be our targets as many microbes are needed for balancing of ecology of the human body. The short listed 238 protein sequences which were non-human homologs were then compared with the gut flora and it was found that 20 of them were non-human and non-gut floral sequence homologs, leaving 87% of the non-homologous sequences to gut flora as our confident drug targets. The products of these selected genes were mapped to biological pathwaysand it was found these putative target proteins were involved in processes. The involvement of putative proteins in biological make them an essentiality for structure and survival ability of Candida. The gene ontology of twenty selected proteins indicated thatthese proteins weremostly cytoplasmic in origin, followed by mitochondrial and cell wall proteins (Muhammad et al., 2014) . Out of 20 proteins, 4were further modelled for the docking studies using a Swiss model template. The template with the highest quality has been identified and selected for the model building (Remmert et al., 2011; Guex & Peitsch, 1997; Bordoli et al., 2009; Sali & Blundell, 1993; Benkert et al., 2011; Benkert et al., 2009; Biasini et al., 2014) . The QMEAN scoring function was used for the assessment of the global and per-residue model. These homology models may be used for used for computational analysis of new ligand, ligand designing and ligand modification. The present antifungal drug can also be studied for their bonding affinities with these putative target proteins. These homology model are already being used for some antifungal docking studies (unpublished data). These protein models provide useful template for designing of novel drugs, as well as studies of old ligands against these putative targets. The homology models provide a good template to identify the selective targets in any species and selective toxicity of drug/ligand toward that species.
The selective toxicity of compound is very important as the natural human flora act as an organ of human body, providing nutrients like folic acid, are responsible for mood stabilization and have a commensal function to not allowing pathogenic species to grow. Further studies and a refined modeling algorithm will help us to design a tailor made drug towards a selected target of a given species 
